Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations | Haematologica
Frequency of phenotypic mutations among Polycythemia Vera (A),... | Download Scientific Diagram
Estimate of survival of 867 patients with essential thrombocythemia, by... | Download Scientific Diagram
Distribution of driver mutations in polycythemia vera (PV), essential... | Download Scientific Diagram
CALR mutations and a new diagnostic algorithm for MPN | Nature Reviews Clinical Oncology
Essential Thrombocytosis: Practice Essentials, Pathophysiology, Epidemiology
Diagnostic Criteria for Essential Thrombocythemia According to the BSH... | Download Scientific Diagram
Personalized management of essential thrombocythemia—application of recent evidence to clinical practice | Leukemia
Contemporary Approach CALR Positive MPNs - MPN Cancer Connection
Essential thrombocythemia (ET) – MPN Research Foundation
Essential thrombocythemia (ET) – MPN Research Foundation
Essential thrombocythemia: challenges in clinical practice and future prospects - ScienceDirect
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations | Haematologica
Essential thrombocythemia (ET) – MPN Research Foundation
Mutations and thrombosis in essential thrombocythemia | Blood Cancer Journal
Essential Thrombocythemia
Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era | Leukemia
IJMS | Free Full-Text | The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms
JAK2 Reflex for Essential Thrombocythemia
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation | Haematologica
Main clinicohematological characteristics at diagnosis in 433 patients... | Download Table
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Essential Thrombocytosis: Practice Essentials, Pathophysiology, Epidemiology
Type 1-like CALR mutants induce a stronger essential... | Download Scientific Diagram
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation | Haematologica
